ECG-AI Pulmonary Hypertension PH-12L Algorithm is a Phase 7 candidate from the FDA AI-enabled medical devices list. Maker: Anumana. Panel: Cardiovascular. HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.
